Eli Lilly And Co vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Eli Lilly And Co trades at $1,174.02 (market cap $1.02T), while iShares 10 20 Year Treasury Bond ETF trades at $97.83. The key difference: Eli Lilly And Co pays a 0.6% dividend while iShares 10 20 Year Treasury Bond ETF pays none. Which is the better fit depends on your goals.
| LLY | TLH | |
|---|---|---|
Market Cap | $1.02T | — |
Sector | Health | Fixed Income |
52-Week High | $1.24K | $105.36 |
52-Week Low | $625.65 | $97.13 |
Enterprise Value | $1.06T | — |
Dividend Yield | 0.6% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLH trades at $98.13, down 0.56% today amid a bearish technical signal. The stock faces selling pressure with moving averages indicating a downtrend, while oscillators remain neutral. Recent dividends of $0.41 and $0.36 for H1-26 and H2-26 signal shareholder returns, but key valuation and profitability ratios are unavailable, limiting fundamental clarity.
The outlook is cautious due to bearish technicals and lack of financial metrics. Risks include market volatility from geopolitical tensions and Fed policy uncertainty. Investors need updated earnings and guidance to assess growth potential amid macroeconomic headwinds highlighted in recent financial news.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →